Application no. and date | 09176390.4 (espacenet) (Federated) (European Patent Register), 20010927 | Patent/reg. no. and date | DK/EP 2158905, 20130320 | Publication date | 20100303 | Priority no. and date | US 236973, 20000929, US 284017, 20010416 | EP pub. no. and date |
EP 2158905 20100303 | Effective date | | Applicant/owner | 3M Innovative Properties Company, 3M Center Post Office Box 33427
Saint Paul, MN 55133-3427, US | Applicant ref. no. | 3M 56032 | Inventor | Cantor, S. Adam, W9281 710th Avenue
River Falls, WI 54022, US, Ocheltree, W. Terrance, 3713 Ridge View Way
Lexington, KY 40509, US, Robles, A. Cynthia, 1110 174th Avenue
New Richmond, WI 54017, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/4468 (2006.01) , A61K 9/70 (2006.01) | Title | Sammensætning til transdermal administration af fentanyl | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|